Real-world safety and effectiveness of entrectinib in Japanese patients with ROS1 gene fusion-positive, unresectable, advanced/recurrent non-small cell lung cancer: Post-marketing surveillance

Authors

Akira Murayama
Mizuki Kobayashi (ORCID: https://orcid.org/0000-0002-4135-6789)
Yuya Ueda (ORCID: https://orcid.org/0000-0001-8069-9429)
Lyu Ji
Noboru Yamamoto (ORCID: https://orcid.org/0000-0002-0787-2851)
Haruo Sugano
Takashi Seto (ORCID: https://orcid.org/0000-0002-2960-4364)
Sayuri Nakane (ORCID: https://orcid.org/0009-0001-2733-3265)
N. Takei

Institutions

National Hospital Organization Kyushu Cancer Center (JP)
Chugai Pharma (United States) (US)
Tokyo National Hospital (JP)

Publication Details

Journal: Lung Cancer
Published: 2025-03-12
DOI: https://doi.org/10.1016/j.lungcan.2025.108478
Citations: 1
Primary Topic: Lung Cancer Treatments and Mutations
Type: article
Field-Weighted Citation Impact: 1.52

Funders

Chugai Pharmaceutical

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Real-world safety and effectiveness of entrectinib in Japanese patients with ROS1 gene fusion-positive, unresectable, advanced/recurrent non-small cell lung cancer: Post-marketing surveillance

Akira Murayama, Mizuki Kobayashi, Yuya Ueda, Lyu Ji et al.

Mar 12, 2025

1 citations

Lung Cancer

Lung Cancer Treatments and Mutations

1.52

article

Real-world safety and effectiveness of entrectinib in Japanese patients with ROS1 gene fusion-positive, unresectable, advanced/recurrent non-small cell lung cancer: Post-marketing surveillance

Akira Murayama, Mizuki Kobayashi, Yuya Ueda, Lyu Ji, Noboru Yamamoto, Haruo Sugano, Takashi Seto, Sayuri Nakane, N. Takei

March 12, 2025article en

1 citations

Abstract

No abstract available for this paper.

Lung CancerVol. 203

National Hospital Organization Kyushu Cancer Center (JP), Chugai Pharma (United States) (US), Tokyo National Hospital (JP)

Chugai Pharmaceutical

Openalex Percentile: Top 21%

Lung Cancer Treatments and Mutations

1.52

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.